Fingerprint
Dive into the research topics of 'Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically